eculizumab
0 sources
eculizumab
Summary
eculizumab is a type of chemical entity[1]. eculizumab ranks in the top 5% of type_of_chemical_entity entities by monthly Wikipedia readership (86 views/month).[2]
Key Facts
- eculizumab's instance of is recorded as type of chemical entity[3].
- eculizumab's CAS Registry Number is recorded as 219685-50-4[4].
- eculizumab's ATC code is recorded as L04AA25[5].
- eculizumab's subclass of is recorded as chemical compound[6].
- eculizumab's has use is recorded as medication[7].
- eculizumab's Commons category is recorded as Eculizumab[8].
- eculizumab's MeSH descriptor ID is recorded as C481642[9].
- eculizumab's ChEMBL ID is recorded as CHEMBL1201828[10].
- eculizumab's Guide to Pharmacology Ligand ID is recorded as 6884[11].
- eculizumab's route of administration is recorded as intravenous infusion and defusionههبهلخل[12].
- eculizumab's Freebase ID is recorded as /m/0h3htt[13].
- eculizumab's UNII is recorded as A3ULP0F556[14].
- eculizumab's DrugBank ID is recorded as DB01257[15].
- eculizumab's has characteristic is recorded as biopharmaceutical[16].
- eculizumab's HSDB ID is recorded as 8394[17].
- eculizumab's mass is recorded as {'unit': 'Q14623804', 'amount': '+148'}[18].
- eculizumab's NDF-RT ID is recorded as N0000176091[19].
- eculizumab's medical condition treated is recorded as glomerulonephritis[20].
- eculizumab's medical condition treated is recorded as thrombotic microangiopathy[21].
- eculizumab's medical condition treated is recorded as paroxysmal nocturnal hemoglobinuria[22].
- eculizumab's medical condition treated is recorded as membranoproliferative glomerulonephritis[23].
- eculizumab's medical condition treated is recorded as hemolytic-uremic syndrome[24].
- eculizumab's medical condition treated is recorded as myasthenia gravis[25].
- eculizumab's World Health Organisation international non-proprietary name is recorded as {'lang': 'en', 'text': 'eculizumab'}[26].
- eculizumab's subject has role is recorded as monoclonal antibody[27].
Why It Matters
eculizumab ranks in the top 5% of type_of_chemical_entity entities by monthly Wikipedia readership (86 views/month).[2] eculizumab has Wikipedia articles in 13 language editions, a strong signal of global cultural recognition.[28] eculizumab is known by 13 alternative names across languages and contexts.[29]